In another study using DLBCL cell lines, downregulation of BFL-1 using shRNAs caused cells to become more sensitive to apoptosis induced by Rituximab and chemotherapies [43]. The gene discussed is BCL2A1; the disease is diffuse large B-cell lymphoma.